Literature DB >> 10822128

Involvement of SAPK/JNK pathway in X-ray-induced rapid cell death of human T-cell leukemia cell line MOLT-4.

A Enomoto1, N Suzuki, K Hirano, Y Matsumoto, A Morita, K Sakai, H Koyama.   

Abstract

We found that SAPK/JNK was phosphorylated during X-ray-induced rapid cell death of MOLT-4 cells and that acid Sphingomyelinase inhibitor D609 suppressed the rapid cell death as well as phosphorylation of SAPK/JNK. Also C2-ceramide caused phosphorylation of SAPK/JNK, followed by rapid cell death. Further we isolated X-ray-resistant radiation-hybrid clones from MOLT-4 and 50 Gy irradiated mouse FM3A cells by repeated selections with 3 Gy irradiation. One of them named Rh-1a was found resistant to X-ray- as well as C2-ceramide-induced rapid cell death. Rh-1a cells had mouse DNA but no increase in either mouse or human Bcl-2 determined by Western blotting. Accumulation of p53 after X-irradiation was similarly observed in both parental MOLT-4 and Rh-1a cells. However, contrasting to prolonged and prominent phosphorylated status of SAPK/JNK in MOLT-4 cells, Rh-1a cells exhibited short transient increase and FM3A cells showed no increase of phosphorylated status SAPK/JNK after X-irradiation. Therefore, SAPK/JNK activation is considered important in X-ray-induced rapid cell death or apoptosis of MOLT-4 cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822128     DOI: 10.1016/s0304-3835(00)00422-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  The antimicrotubule drug estramustine but not irradiation induces apoptosis in malignant glioma involving AKT and caspase pathways.

Authors:  Christina Vallbo; Tommy Bergenheim; Håkan Hedman; Roger Henriksson
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

2.  Evaluation of zinc (II) chelators for inhibiting p53-mediated apoptosis.

Authors:  Akinori Morita; Shinya Ariyasu; Soichiro Ohya; Ippei Takahashi; Bing Wang; Kaoru Tanaka; Takatoshi Uchida; Haruna Okazaki; Kengo Hanaya; Atsushi Enomoto; Mitsuru Nenoi; Masahiko Ikekita; Shin Aoki; Yoshio Hosoi
Journal:  Oncotarget       Date:  2013-12

Review 3.  Crosstalk between NLRP12 and JNK during Hepatocellular Carcinoma.

Authors:  Shahanshah Khan; Hasan Zaki
Journal:  Int J Mol Sci       Date:  2020-01-13       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.